Efficacy and Safety of Adjunctive Recombinant Human Interleukin-2 for Patients with Pulmonary Tuberculosis: A Meta-Analysis

Background. The results of previous clinical trials evaluating the efficacy and safety of recombinant human interleukin-2 (rhuIL-2) for adult patients with pulmonary tuberculosis showed inconsistent results. Accordingly, a comprehensive systematic review and meta-analysis was performed. Methods. Rel...

Full description

Saved in:
Bibliographic Details
Main Authors: Lina Sheng, Xiaofei Li, Fangbin Weng, Shuang Wu, Yongxin Chen, Lianqing Lou
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Tropical Medicine
Online Access:http://dx.doi.org/10.1155/2022/5071816
Tags: Add Tag
No Tags, Be the first to tag this record!